Check Cap Ltd
NASDAQ:CHEK
Check Cap Ltd
NASDAQ:CHEK
Price:
141
USD
-0.7%
Market Closed
Market Cap:
$8.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Check Cap Ltd
Total Assets
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Check Cap Ltd
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Check Cap Ltd
NASDAQ:CHEK
|
Total Assets
$377k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Total Assets
$113.1m
|
CAGR 3-Years
19%
|
CAGR 5-Years
27%
|
CAGR 10-Years
17%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Total Assets
$766.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
Total Assets
$657.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
Total Assets
$105.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Total Assets
$55.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Check Cap Ltd
Glance View
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. The company employs 81 full-time employees The company went IPO on 2015-02-19. The firm develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.
CHEK
Intrinsic Value
4.29
USD
Overvaluation 97%
See Also
What is Check Cap Ltd's Total Assets?
Total Assets
377k
USD
377k
USD
Based on the financial report for Dec 31, 2024, Check Cap Ltd's Total Assets amounts to 377k USD.
What is Check Cap Ltd's Total Assets growth rate?
Total Assets CAGR 1Y
-98%
-98%
Over the last year, the Total Assets growth was -98%.
